S020-2621 Screening compound: 2-(4-METHOXYPHENYL)-7-[2-(3-THIENYL)ACETYL]-5,6,7,8-TETRAHYDROPYRIDO[3,4-D]PYRIMIDIN-4(1H)-ONE

S020-2621 Screening compound: 2-(4-METHOXYPHENYL)-7-[2-(3-THIENYL)ACETYL]-5,6,7,8-TETRAHYDROPYRIDO[3,4-D]PYRIMIDIN-4(1H)-ONE
S020-2621 Screening compound: 2-(4-METHOXYPHENYL)-7-[2-(3-THIENYL)ACETYL]-5,6,7,8-TETRAHYDROPYRIDO[3,4-D]PYRIMIDIN-4(1H)-ONE alternative view

Chemical Structure Depiction of ChemDiv screening compound S020-2621
2-(4-METHOXYPHENYL)-7-[2-(3-THIENYL)ACETYL]-5,6,7,8-TETRAHYDROPYRIDO[3,4-D]PYRIMIDIN-4(1H)-ONE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S020-2621

Molecular Formula

C20H19N3O3S (C20 H19 N3 O3 S)

Compound Name

2-(4-METHOXYPHENYL)-7-[2-(3-THIENYL)ACETYL]-5,6,7,8-TETRAHYDROPYRIDO[3,4-D]PYRIMIDIN-4(1H)-ONE

IUPAC name

n/a

SMILES

COc(cc1)ccc1C(NC(C1)=C2CCN1C(Cc1cscc1)=O)=NC2=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

381.46

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

2.319

Distribution Coefficient, logD

0.469

Water Solubility, LogSw

-2.81

Polar Surface Area

59.286

Acid Dissociation Constant (pKa)

5.56

Base Dissociation Constant (pKb)

3.39

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

25.00

S020-2621 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • Epigenetic
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds
Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • Others

References: we are preparing a list of scientific research reports with S020-2621 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S020-2621?
Check Price and Availability of S020-2621, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S020-2621 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S020-2621
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S020-2621
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S020-2621 available by request